Belviq Weight-Loss Drug Cancer Lawsuits

Belviq Lorcaserin Weight-Loss Drug Lawyer

Diagnosed With Cancer After Taking Belviq (Lorcaserin) for Weight Loss?

A Belviq weight-loss drug lawyer may be able to help if you have been diagnosed with certain cancers after the use of Belviq (Lorcaserin) for weight loss. Belviq and Belviq XR are the brand names of the drug Lorcaserin–a widely-used weight loss drug.  In February of 2020, the Federal Drug Association issued a full recall of all Belviq, Belviq, XR, and Lorcaserin products following the results of a clinical trial that showed an increased risk of developing pancreatic cancer, colorectal cancer, and lung cancer in people taking Belviq, Belviq, XR, and generic Lorcaserin. If you were a user of this weight loss drug and subsequently developed one of these cancers, you may be entitled to compensation.  Call 1-800-298-0111 to be connected with a Houston Belviq weight-loss drug lawyer to discuss your options.

What is Belviq and Belviq XR (Lorcaserin)?

Belviq/Belviq XR s is a serotonin 2C receptor agonist–a substance that activates the serotonin receptors in the brain to create a feeling of satisfaction or fullness. It was indicated as a weight-loss medication that, when taken with regular diet and exercise, could help some adults living with extra weight, with a weight-related medical problem, or adults living with obesity, lose weight and keep it off. Belviq is taken orally. The recommended dosage of Belviq is one 10mg tablet taken twice per day.  The drug was originally manufactured by Arena Pharmaceuticals and later sold and distributed pursuant to an agreement with Eisai.

Known Cancer Risk History and the Belviq Recall

product recallArena Pharmaceuticals, the original maker of Belviq, had early warnings that Belviq could increase the risk of cancer. In October 2010 the FDA denied the Arena Pharmaceuticals ‘ application to approve Belviq due to concern that it was causing tumors in rats. Those studies involved rodents who developed brain and breast cancer after being given doses of Belviq that were 7-times the dose a human would receive.

In 2012, Arena Pharmaceuticals resubmitted the drug application with new data to assure the FDA there was not a significant cancer risk to humans. Arena Pharmaceuticals assured the FDA that the tumors were rodent-specific and did not apply to humans.  Belviq was then approved for distribution in June 2012 relying upon this new information.

In 2017, Arena Pharmaceuticals entered into a Marketing and Supply Agreement with Eisai Co., Ltd. and Eisai Inc. (collectively, “Eisai”) giving Eisai global commercialization rights to Belviq. Arena and Eisai were required to submit the drug to a 5-year safety study by the FDA known as the CAMELLIA-TIMI 61 trial. The results of the 2020 safety trial found that there was a higher instance of several cancers in humans taking the drug vs a control group and that Belviq users particularly demonstrated higher instances of pancreatic, colorectal, and lung cancer. This was a five-year double-blind study involving 12,000 users of Belviq. As a result of the study, Eisai issued a voluntary recall and withdrawal from the market of Belviq, Belviq, XR, and Lorcaserin.

Belviq weight loss drug lawyers have filed multiple lawsuits against the manufacturers seeking millions in damages for plaintiffs who used the weight-loss drug and then were diagnosed with cancer. The underlying data from the above studies and any other research done by the manufacturers will likely be the focus of the discovery process.

What Cancers Has Belviq Been Linked to?

The FDA’s 2020 safety trials concluded that there was a higher instance of several different cancers in persons taking Belaviq but that the were three that stood out.  Pancreatic cancer, colorectal cancer, and lung cancer all appear to occur more frequently in users of Belaviq.

What Should I do If I Took Belviq?

Belviq, Belviw, XR, and Lorcaserin are recalled products. If you have taken these products in the past and were subsequently diagnosed with pancreatic cancer, colorectal cancer, or lung cancer, talk to a  Belviq weight loss drug lawyer handling cancer claims related to the Belviq Lorcaserin weight loss drugs to learn your rights.  Call us at 1-800-298-0111 to be connected with an attorney today. We associate with other law firms for the handling of some mass tort claims.

Warning: Do not stop taking a prescribed medication without first consulting a physician.

Author